We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Itasca Wines is a Hampshire-based vineyard and winery that produces fine English wines. The company is raising funds for its contract winemaking facility, to fulfil the growing demand from vineyards. There are over 760 vineyards in the UK currently, 111 have their own winery and only a handful of these provide contract winemaking services to other vineyards. Itasca Wines aims to become a major winemaker and create award-winning wines at Penn Croft. The company planted its first vineyard of 16,000 vines in May 2019 and has featured in Vineyard Magazine in February and May 2019.

Pitch Rated

76%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,147,003
Bodytrak is a wearable technology that monitors physiological activity such as heart rate and core body temperature.  This real time data is analysed using cloud based technology and algorithms to supervisors or commanders so early action can be taken on the event of illness or injury.
days to go: Expired investment: £1,123,119
WhiskyInvestDirect leverages BullionVault’s proven model of crowdfunding wholesale bullion bars (25,000 UK clients) and applies it to maturing whisky. The model eliminates the key working capital constraint experienced by producers, whilst users can potentially profit as the whisky increases in value. The team includes the founder and CEO of BullionVault and an ex-Commercial Director at Diageo who has been building whisky brands for the last 24 years.
days to go: Expired investment: £1,076,472
BorrowMyDoggy connect dog owners with other local dog lovers across the UK. At Borrowmydoggy, you can arrange dog walking and dog sitting. All you have to do is; create a profile, search for local lenders/ borrowers and then arrange a meeting to see if they'll be a good match. 
days to go: Expired investment: £1,054,490
Tamoco Limited are a provider of online data, creating actionable data and aggregating precise consumer location data. Tamoco provides brands with a method of understanding how audiences behave with speed and accuracy, and delivers an innovative content delivery platform for advertisers. The platform utilises precise location to present content relevant to its audience.     
days to go: Expired investment: £1,050,000
MedicSpot is a healthcare company that is aiming to revolutionise healthcare delivery by combining the advantages of online and offline care. The company provides patients at designated hospitals with diagnostic tools like a stethoscope, oximeter, blood pressure monitor and thermometer which, in turn, is connected to the MedicSpot network. Onboard General Physicians (GPs) engage in live sessions with patients, guide them on how to use the tools, and perform a variety of diagnoses like listening to a patient’s heart and lungs, looking down their throat and into their ears, taking their blood pressure and oxygen readings, and measuring their body temperature. The company is also expanding into another subsidiary, Arc Health, which it claims will perform the aforementioned tasks with more efficiency and accuracy. The company will use the investment to increase the number of Medicspot clinics to 1,000, gain further NHS market share, launch a corporate business model and allow international pilots to take place.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,048,396
Ancon is designed to detect trace elements of things such as explosives, drugs and chemical weapons in the air. Ancon manufactures equipment and components that are up to 10,000 times more sensitive then anything else on the market.
days to go: Expired investment: £1,043,525
Ancon manufacture equipment and components that detect trace elements of explosives, drugs and chemical weapons in the air. Ancons technology is roughly 10,000 times more sensitive than anything currently on the market.
days to go: Expired investment: £1,043,525
Zentraxa is focused on precision bioengineering to produce peptides with predictable properties tailored towards purpose. The company points out that peptides are amino acids that are the building blocks of certain proteins needed by the skin, like collagen and elastin. It has come out with a synthetic biology platform, Zentide, that designs, produces and tests novel peptides. Zentraxa argues that Zentide can circumvent previously existing bio-design limits imposed by conventional peptide synthesis and produce tailor-made biomaterials for healthcare, personal care and industrial uses. Zentraxa is initially targeting healthcare with its first biomaterial, a debondable adhesive, for use in wound care. The company asserts that the material has other uses such as cosmetics and industrial applications due to its ability to bond strongly while still being easily and painlessly removable. Zentraxa will use the investment to create a portfolio of other biomaterials for licensing to global businesses in the health and industrial sectors via its Zentide platform. 
days to go: Expired investment: £1,040,000
SilkFred is a curated online marketplace for over 200 independent fashion brands. It’s a destination for customers seeking to differentiate their wardrobes. SilkFred cuts through the noise of online shopping and provides a central destination for female shoppers to find affordable pieces that their friends won’t have (and will love!). Having cultivated a cult social media status and attracted a growing number of loyal shoppers and brands, SilkFred is now ready to scale its business model rapidly. www.silkfred.com
days to go: Expired investment: £906,630
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph